Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT06712485
Starting soon Observational

Biomarkers in EV Associated With Marrow Adiposity in Anorexia

NCT06712485 · tracked via the Priya Life Science Spain tracker
Sponsor
Maimónides Biomedical Research Institute of Córdoba
Phase
Observational
Started
2025-05-15
Last updated
2025-05-07

Condition(s) studied

Anorexia Nervosa Restricting TypeAnorexia Nervosa (DSM-IV Revised Criteria)

Study summary

The aim of this observational study is to identify biomarkers in extracellular vesicles associated with medullary adiposity occurring in patients with anorexia nervosa. The main question it aims to answer is:

Can this medullary adiposity be associated with the bone deterioration observed in this population?

Participants will be assessed for body composition and a blood sample will be taken by non-invasive techniques.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: For AN group: * Diagnosis of active AN according to DSM-5 criteria * BMI of less than 17kg/m2 * Present amenorrhoea in the 3 months prior to the start of the study. For AN-R group: * Achieved weight gain of more than 85%. * Normal menstruation in the last 3 months. For Control group: * Population of the same age and gender as the AN and AN-R groups. * If pubertal population, presenting a chronological age of ± 2 years. * Normal menstruation * Normal BMI (\>18.5 kg/m2) * No presence of previous dietary transtrons. Exclusion Criteria: * Not receiving oestrogens, contraceptives or glucocorticoids in the 3 months prior to the start of the study. * Not to suffer from chronic diseases, such as diabetes, pathologies affecting the bone system or thyroid function. * Do not take calcium or vitamin supplements.

Primary outcome measure(s)

  • Biomarkers related to medullary adiposity — 1 day
    Blood samples to isolate extracellular vesicles for omics studies

Trial sites (1)

FacilityCityRegionStatus
Hospital Universitario Reina Sofía, Edificio IMIBIC, Avd. Menedez Pdial, s/n Córdoba Córdoba

More Maimónides Biomedical Research Institute of Córdoba trials in Spain

Exploring Minor Proteins and Peptides in Human Milk: a Proteomic Analysis Across Lactation Stages Recruiting
Recovery After Fatigue in Young Athletes: Comparison Between TECAR Therapy and Cycle Ergometer" Recruiting
FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease. Recruiting
Programme for Intervention in Paediatric Obesity Recruiting
Digital Health Education to Improve Cardiovascular Health Across Different Socioeconomic Groups: e-DUCASS Advance Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06712485 on ClinicalTrials.gov ↗ ← All trials in Spain